MiMedx Group Analyst Ratings
MiMedx Group Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/31/2023 | 86.05% | Mizuho | $14 → $12 | Maintains | Buy |
| 10/27/2023 | 86.05% | Craig-Hallum | → $12 | Initiates Coverage On | → Buy |
| 08/02/2023 | 86.05% | Mizuho | $10 → $12 | Maintains | Buy |
| 08/02/2023 | 70.54% | HC Wainwright & Co. | $8 → $11 | Maintains | Buy |
| 06/21/2023 | 24.03% | HC Wainwright & Co. | $9.5 → $8 | Maintains | Buy |
| 05/03/2023 | 47.29% | HC Wainwright & Co. | $8 → $9.5 | Maintains | Buy |
| 03/02/2023 | 24.03% | HC Wainwright & Co. | → $8 | Reiterates | → Buy |
| 10/13/2022 | 8.53% | Mizuho | → $7 | Initiates Coverage On | → Buy |
| 09/07/2022 | 24.03% | HC Wainwright & Co. | $8.5 → $8 | Maintains | Buy |
| 09/14/2021 | 31.78% | HC Wainwright & Co. | $20 → $8.5 | Maintains | Buy |
| 07/26/2021 | 256.59% | Northland Capital Markets | → $23 | Initiates Coverage On | → Outperform |
| 03/19/2021 | 210.08% | HC Wainwright & Co. | → $20 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 2023年10月31日 | 86.05% | 瑞穗 | $14→$12 | 维护 | 买 |
| 2023年10月27日 | 86.05% | 克雷格-哈勒姆 | →$12 | 开始承保 | →购买 |
| 08/02/2023 | 86.05% | 瑞穗 | $10→$12 | 维护 | 买 |
| 08/02/2023 | 70.54% | HC Wainwright公司 | $8→$11 | 维护 | 买 |
| 2023年6月21日 | 24.03% | HC Wainwright公司 | $9.5→$8 | 维护 | 买 |
| 05/03/2023 | 47.29% | HC Wainwright公司 | $8→$9.5 | 维护 | 买 |
| 03/02/2023 | 24.03% | HC Wainwright公司 | →$8 | 重申 | →购买 |
| 10/13/2022 | 8.53% | 瑞穗 | →$7 | 开始承保 | →购买 |
| 09/07/2022 | 24.03% | HC Wainwright公司 | $8.5→$8 | 维护 | 买 |
| 09/14/2021 | 31.78% | HC Wainwright公司 | $20→$8.5 | 维护 | 买 |
| 07/26/2021 | 256.59% | 北国资本市场 | →$23 | 开始承保 | →跑赢大盘 |
| 03/19/2021 | 210.08% | HC Wainwright公司 | →$20 | 开始承保 | →购买 |
What is the target price for MiMedx Group (MDXG)?
MiMedx Group(MDXG)的目标价是多少？
The latest price target for MiMedx Group (NASDAQ: MDXG) was reported by Mizuho on October 31, 2023. The analyst firm set a price target for $12.00 expecting MDXG to rise to within 12 months (a possible 86.05% upside). 7 analyst firms have reported ratings in the last year.
瑞穗于2023年10月31日报道了MiMedx集团(纳斯达克：MDXG)的最新目标价。这家分析公司将MDXG的目标价设定为12.00美元，预计MDXG将在12个月内上涨(可能上涨86.05%)。去年有7家分析公司公布了评级。
What is the most recent analyst rating for MiMedx Group (MDXG)?
MiMedx Group(MDXG)的最新分析师评级是什么？
The latest analyst rating for MiMedx Group (NASDAQ: MDXG) was provided by Mizuho, and MiMedx Group maintained their buy rating.
瑞穗对MiMedx Group(纳斯达克代码：MDXG)的最新分析师评级为买入，MiMedx Group维持买入评级。
When is the next analyst rating going to be posted or updated for MiMedx Group (MDXG)?
MiMedx Group(MDXG)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of MiMedx Group, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for MiMedx Group was filed on October 31, 2023 so you should expect the next rating to be made available sometime around October 31, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括查阅公共财务报表，与MiMedx集团的高管和客户交谈，以及听取收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。MiMedx集团的上一次评级是在2023年10月31日提交的，因此您应该预计下一次评级将在2024年10月31日左右提供。
Is the Analyst Rating MiMedx Group (MDXG) correct?
分析师对MiMedx Group(MDXG)的评级正确吗？
While ratings are subjective and will change, the latest MiMedx Group (MDXG) rating was a maintained with a price target of $14.00 to $12.00. The current price MiMedx Group (MDXG) is trading at is $6.45, which is out of the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的MiMedx Group(MDXG)评级维持不变，目标价在14.00美元至12.00美元之间。MiMedx Group目前的交易价格为6.45美元，超出了分析师的预测区间。